Tag: Jardiance

Jardiance receives FDA approval to tackle kidney disease and cardiovascular risks

The U.S. Food and Drug Administration (FDA) has granted approval for Jardiance (empagliflozin) 10 mg tablets, a significant development announced jointly by Boehringer Ingelheim and ... Read More